Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ABT-199 demonstrates antitumor activity in patients with NHL

Dec. 28, 2012

Clinical trial notification accepted in Japan for phase I oral rigosertib trial

Dec. 28, 2012

NewGen Therapeutics discloses novel PARP-1 inhibitors

Dec. 28, 2012

Favorable results presented for BC-2059, a novel beta-catenin inhibitor

Dec. 28, 2012

U.K. researchers develop novel model of B-cell and myeloid malignancies

Dec. 28, 2012

A dual SYK/JAK inhibitor shows potential in animal models of arthritis and B-cell malignancies

Dec. 27, 2012

Only For Children Pharmaceuticals withdraws MAA for Loulla

Dec. 27, 2012

Spectrum Pharmaceuticals' pivotal BELIEF trial meets primary endpoint

Dec. 27, 2012

Endo returns global rights for Urocidin

Dec. 27, 2012

U.S. researchers design novel heterodimeric targeting ligands

Dec. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...